Search results
KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year - KalVista Pharma...
Benzinga· 4 days agoKALV, today announced its strategic plans for fiscal year 2025, beginning May 1, including for sebetralstat, the Company's investigational novel, oral plasma kallikrein inhibitor for the on-demand ...